Clinical Trials Browser

Unknown × Hematologic Neoplasms × venetoclax × Clear all

NCT04809181 2023-02-21

Azacitidine in Combination With Venetoclax Treatment for MRD Positive Post Allo-HSCT AML/MDS Patients

Phase 2 Unknown

Other hematologic neoplasm

Recurrence, Hematologic Neoplasms